Emilie Le Rhun
Expertise in
12
conditions

Emilie Le Rhun

Zurich, ZH, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
12
conditions
Zurich, ZH, CH 

Overview

Emilie Le Rhun practices practicing medicine in Zurich, Switzerland.

Ms. Le Rhun is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Brain Tumor, Glioblastoma, Astrocytoma, and Glioma.

She is actively involved in clinical research, co-authoring 268 peer reviewed articles and participating in 6 clinical trials.

Gender

Female

Locations

Zurich, ZH, Switzerland
Other Locations
Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Enrollment Status: Recruiting
Publish Date: June 24, 2026
Intervention Type: Genetic
A Phase 1 Study of LY3200882 in Patients With Solid Tumors
A Phase 1 Study of LY3200882 in Patients With Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2026
Intervention Type: Drug, Radiation
Study Phase: Phase 1
Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases
Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 16, 2026
Intervention Type: Other
Study Phase: Not Applicable
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: July 01, 2025
Intervention Type: Drug, Radiation
Study Drugs: Marizomib, Temozolomide
Study Phase: Phase 3
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma
Enrollment Status: Completed
Publish Date: March 08, 2024
Intervention Type: Procedure
View 5 Less Clinical Trials

268 Total Publications

Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).
Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 30, 2026

Frequently Asked Questions about Emilie Le Rhun

Is Emilie Le Rhun a top-rated expert for Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Emilie Le Rhun is classified as an Elite expert for Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Emilie Le Rhun participate in research or clinical trials?

Yes. Emilie Le Rhun has published 268 articles and abstracts on conditions like Brain Tumor. You can view a list of Emilie Le Rhun's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Le Rhun's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile